Search
for
Sort by
Research 631–660 of 1000+
- Bernstein’s Consent and Information on Finasteride and Propecia®
- Finasteride
- PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY
- 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS
- Faculty Opinions recommendation of Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia
- Age-related changes in brain and pituitary 5α-reductase with finasteride (Proscar) treatment
- Comparative Study of Therapeutic Effect of Dibenyline, Finasteride, and Combination Drugs for Symptomatic Benign Prostatic Hyperplasia
- Molecular Interactions of New Pregnenedione Derivatives
- Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: A legitimate approach
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?
- Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5α-reductases 1 and 2
- Ferret adrenal-associated endocrinopathy.
- In-vivo uptake and metabolism of testosterone by the skin and other tissues of the rat
- Inappropriate Sexual Behaviors in Patients with Vascular Dementia: Possible Response to Finasteride
- Role of ACE2 polymorphism in COVID-19: impact of age
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial
- Synthesis and bioactivity of new Finasteride conjugate
- Contrast-Enhanced Ultrasound (CEUS) Evaluation of Canine Prostatic Hyperplasia before and after Osaterone Acetate Therapy: Preliminary Results
- Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States
- Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial
- Serenoa repens (Saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part I
- Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery